Fulgent Genetics, Inc. FLGT Therapeutic Development — General And Administrative Expense

Other segment segments

Similar metrics at other companies

DNLITherapeutics Segment — Other general and administrative expenses

$10.95M+3.1%

DNLITherapeutics Segment — General and administration

$33.51M+14.2%

DNLITherapeutics Segment — Personnel related general and administrative expenses

$22.56M+20.4%

GKOSDevelopment And Commercialization Of Ophthalmic Therapies — General And Administrative Expense

$46.65M+28.8%

ASYSThermal Processing Solutions — General And Administrative Expense

$1.41M+18.4%

WENGlobal Real Estate & Development — General and Administrative Expense

$5.3M+1.5%

Questions, answered.

What is Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense?

Fulgent Genetics, Inc. (FLGT) reported therapeutic development — general and administrative expense of $357K in Q1 2026.

How has Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense changed year-over-year?

Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense increased by 36.8% year-over-year, from $261K to $357K.

What is the long-term trend for Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense?

Over 3 years (2022 to 2025), Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense has grown at a 161.2% compound annual growth rate (CAGR), from $70K to $1.25M.

What does therapeutic development — general and administrative expense mean?

This represents the overhead and administrative costs allocated to the therapeutic development segment, such as management salaries, legal fees, and office expenses. It is used to evaluate the operational efficiency and cost management of the segment's support functions.